Efor Acquires No Deviation to Expand CQV and Compliance Capabilities in Asia

March 2, 2026

Efor, a global quality and compliance platform for the life sciences industry, has announced the acquisition of Singapore-based No Deviation. No Deviation specializes in Commissioning, Qualification & Validation (CQV), Computer System Validation (CSV), quality/compliance, and digital enablement services, and will expand Efor’s regional capabilities across fast-growing Asian biopharmaceutical markets.

Buyers
Efor
Targets
No deviation
Location
Singapore
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.